1. Home
  2. IHS vs PLSE Comparison

IHS vs PLSE Comparison

Compare IHS & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IHS Holding Limited

IHS

IHS Holding Limited

HOLD

Current Price

$7.65

Market Cap

2.5B

ML Signal

HOLD

Logo Pulse Biosciences Inc (DE)

PLSE

Pulse Biosciences Inc (DE)

HOLD

Current Price

$15.20

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IHS
PLSE
Founded
2001
2014
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Medical/Dental Instruments
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
1.2B
IPO Year
2021
2016

Fundamental Metrics

Financial Performance
Metric
IHS
PLSE
Price
$7.65
$15.20
Analyst Decision
Buy
Buy
Analyst Count
7
1
Target Price
$9.32
$22.00
AVG Volume (30 Days)
880.6K
198.5K
Earning Date
11-12-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.37
N/A
Revenue
$1,765,825,000.00
$86,000.00
Revenue This Year
$3.49
N/A
Revenue Next Year
$2.77
$1,002.94
P/E Ratio
$5.43
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.01
$12.56
52 Week High
$8.00
$25.00

Technical Indicators

Market Signals
Indicator
IHS
PLSE
Relative Strength Index (RSI) 62.08 59.06
Support Level $7.09 $13.17
Resistance Level $7.58 $14.91
Average True Range (ATR) 0.23 0.81
MACD -0.00 0.10
Stochastic Oscillator 89.15 74.55

Price Performance

Historical Comparison
IHS
PLSE

About IHS IHS Holding Limited

IHS Holding Ltd is an independent owner, operator, and developer of shared telecommunications infrastructure. The company provides telecommunications infrastructure to its customers, who are MNOs, who in turn provide wireless voice and data services to their end-users. Its geographical segments are Nigeria, Sub-Saharan Africa, the Middle East and North Africa (MENA), and Latin America (Latam). The majority of its revenue is derived from Nigeria.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Share on Social Networks: